Antinuclear antibody testing: A study of clinical utility

Archives of Internal Medicine

Volumn 156, Issue 13, 1996, Pages 1421-1425

  Slater, Cindi A ^a,b,c   Davis, Roger B ^a,c   Shmerling, Robert H ^a,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGED; CASE-CONTROL STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HOSPITALS, TEACHING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEDICAL RECORDS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0029949454     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.13.1421     Document Type: Article

References (21)

1. Margraves M, Richmond M, Morton R. Presentation of two bone marrow elements: the 'tart' cell or LE cell. Mayo Clin Proc. 1948;23:25-28.
2. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
3. Schumacher HR, Klippel JH, Koopman WJ, eds. Primer on the Rheumatic Diseases. 10th ed. Atlanta, Ga. Arthritis Foundation; 1993:328-332.
4. Wilcoxon F. Individual comparisons by ranking methods. Biometrics. 1945;1: 80.
5. Fisher RA. The Design of Experiments. 8th ed. Edinburgh, Scotland: Oliver & Boyd; 1966.
6. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
7. Thomas C, Robinson JA. The antinuclear antibody test: when is a positive result clinically relevant? Postgrad Med. 1993;94:55-66.
8. Carsons S. Newer laboratory parameters for the diagnosis of rheumatic disease. Am J Med. 1988;85:34-38.
9. McCarty GA. Autoantibodies and their relation to rheumatic diseases. Med Clin North Am. 1986;70:237-261.
10. Sulcebe G, Morcka K. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases. Clin Exp Rheumatol. 1992;10:255-261.
11. Richardson B, Epstein WV. Utility of the fluorescent antinuclear antibody test in a single patient. Ann Intern Med. 1981;95:333-338.
12. Svec KH, Veit BC. Age-related antinuclear factors: immunologic characteristics and associated clinical aspects. Arthritis Rheum. 1967;10:509-516.
13. Hooper B, Whittingham S, Mathews JD, Mackay IR, Curnow DH. Autoimmunity in a rural community. Clin Exp lmmunol. 1972;12:79-87.
14. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJE, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp lmmunol. 1987;69:557-565.
15. Wernick R. Avoiding laboratory test misinterpretation in geriatric rheumatology. Geriatrics. 1989;44:61-80.
16. Juby AG, Davis P, McElhaney JE, Gravenstein S. Prevalence of selected autoantibodies in different elderly subpopulations. Br J Rheumatol. 1994;33: 1121-1124.
17. Shmerling RH, Delbanco TL. How useful is the rheumatoid factor? an analysis of sensitivity, specificity, and predictive value. Arch Intern Med. 1992;152: 2417-2420.
18. Miller MH, Littlejohn GO, Jones BW, Strand H. Clinical comparison of cultured human epithelial cells and rat liver as substrates for the fluorescent antinuclear antibody test. J Rheumatol. 1985;12:265-269.
19. Homburger HA. Cascade testing for autoantibodies in connective tissue disease. Mayo Clin Proc. 1995;70:183-184.
20. Griner PF, Mayewski RJ, Mushlin AL, Greenland P. Selection and interpretation of diagnostic tests and procedures: principles and applications. Ann Intern Med. 1981;94:553-592.
21. Liang MH, Meenan RF, Cathcart ES, Schur PH. A screening test strategy for population studies in systemic lupus erythematosus. Arthritis Rheum. 1980; 23:153-157.